Literature DB >> 15110271

Influence of PAMAM dendrimers on human red blood cells.

D M Domański1, B Klajnert, M Bryszewska.   

Abstract

Polyamidoamine (PAMAM) dendrimers with different concentrations (1 nM-1 mM) (generations 2, 3, and 4) impact on human red blood cell morphology, and membrane integrity is studied. Erythrocyte shape changes from biconcave to echinocytic in dendrimers. Cell aggregation occurs. Polymers cause also concentration- and generation-dependent haemolysis.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15110271     DOI： 10.1016/j.bioelechem.2003.09.023

Source DB:  PubMed          Journal:  Bioelectrochemistry        ISSN： 1567-5394            Impact factor:   5.373


  20 in total

1.  PEGylated peptide dendrimeric carriers for the delivery of antimalarial drug chloroquine phosphate.

Authors:  D Bhadra; S Bhadra; N K Jain
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

Review 2.  Preclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.

Authors:  Marina A Dobrovolskaia; Parag Aggarwal; Jennifer B Hall; Scott E McNeil
Journal:  Mol Pharm       Date:  2008-05-30       Impact factor: 4.939

Review 3.  Extracellularly activatable nanocarriers for drug delivery to tumors.

Authors:  Sara A Abouelmagd; Hyesun Hyun; Yoon Yeo
Journal:  Expert Opin Drug Deliv       Date:  2014-06-20       Impact factor: 6.648

4.  The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.

Authors:  Kai Xiao; Yuanpei Li; Juntao Luo; Joyce S Lee; Wenwu Xiao; Abby M Gonik; Rinki G Agarwal; Kit S Lam
Journal:  Biomaterials       Date:  2011-02-04       Impact factor: 12.479

5.  Cationic PAMAM dendrimers disrupt key platelet functions.

Authors:  Clinton F Jones; Robert A Campbell; Zechariah Franks; Christopher C Gibson; Giridhar Thiagarajan; Adriana Vieira-de-Abreu; Sivaprasad Sukavaneshvar; S Fazal Mohammad; Dean Y Li; Hamidreza Ghandehari; Andrew S Weyrich; Benjamin D Brooks; David W Grainger
Journal:  Mol Pharm       Date:  2012-05-04       Impact factor: 4.939

6.  Cationic PAMAM dendrimers aggressively initiate blood clot formation.

Authors:  Clinton F Jones; Robert A Campbell; Amanda E Brooks; Shoeleh Assemi; Soheyl Tadjiki; Giridhar Thiagarajan; Cheyanne Mulcock; Andrew S Weyrich; Benjamin D Brooks; Hamidreza Ghandehari; David W Grainger
Journal:  ACS Nano       Date:  2012-10-24       Impact factor: 15.881

7.  Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.

Authors:  Dipak S Pisal; Venkata K Yellepeddi; Ajay Kumar; Radhey S Kaushik; Michael B Hildreth; Xiangming Guan; Srinath Palakurthi
Journal:  Int J Pharm       Date:  2007-08-26       Impact factor: 5.875

Review 8.  Pre-clinical immunotoxicity studies of nanotechnology-formulated drugs: Challenges, considerations and strategy.

Authors:  Marina A Dobrovolskaia
Journal:  J Control Release       Date:  2015-09-05       Impact factor: 9.776

9.  Zwitterionic chitosan-polyamidoamine dendrimer complex nanoparticles as a pH-sensitive drug carrier.

Authors:  Karen C Liu; Yoon Yeo
Journal:  Mol Pharm       Date:  2013-04-03       Impact factor: 4.939

10.  Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization.

Authors:  Yu Nie; Li Ji; Hong Ding; Li Xie; Li Li; Bin He; Yao Wu; Zhongwei Gu
Journal:  Theranostics       Date:  2012-11-13       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.